The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization

Targeting Pan-Resistant Bacteria With Antibodies to a Broadly Conserved Surface Polysaccharide Expressed During Infection

(2012) David Skurnik et al.   JOURNAL OF INFECTIOUS DISEASES

Passive immunity in the prevention of rabies

(2012) Leonard Both et al.   LANCET INFECTIOUS DISEASES

Guillain–Barré Syndrome

(2012) Nobuhiro Yuki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

(2012) Guanpingshen Luo et al.   PLoS One

Acinetobacter baumannii

(2012) Aoife Howard et al.   Virulence

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

(2012) Ignasi Roca et al.   Frontiers in Microbiology

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies

(2011) Marco AP Sáfadi et al.   Expert Review of Vaccines

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe

(2011) David S Fedson et al.   Expert Review of Vaccines

Long-term protection after immunization with protein–polysaccharide conjugate vaccines in infancy

(2011) Geraldine Blanchard-Rohner et al.   Expert Review of Vaccines

Haemophilus influenzaetype b–Neisseria meningitidisserogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers

(2011) Kristina A Bryant et al.   Expert Review of Vaccines

Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases

(2011) Jennifer L. Hsu et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Antibiotics in the clinical pipeline in 2011

(2011) Mark S Butler et al.   JOURNAL OF ANTIBIOTICS

Treatment ofAcinetobacterInfections

(2010) Joel Fishbain et al.   CLINICAL INFECTIOUS DISEASES

The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor

(2010) T. A. Russo et al.   INFECTION AND IMMUNITY

Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis

(2010) N. R. Luke et al.   INFECTION AND IMMUNITY

Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: Systematic review

(2010) Rosalyn E. O’Loughlin et al.   VACCINE

How Bacterial Carbohydrates Influence the Adaptive Immune System

(2009) Fikri Y. Avci et al.   Annual Review of Immunology

The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation

(2009) A. H. K. Choi et al.   JOURNAL OF BACTERIOLOGY

Penicillin‐Binding Protein 7/8 Contributes to the Survival ofAcinetobacter baumanniiIn Vitro and In Vivo

(2009) Thomas A. Russo et al.   JOURNAL OF INFECTIOUS DISEASES

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Why are we afraid of Acinetobacter baumannii?

(2008) Federico Perez et al.   Expert Review of Anti-Infective Therapy

Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology

(2008) T. A. Russo et al.   INFECTION AND IMMUNITY

Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine

(2008) Thomas A. Russo et al.   VACCINE